NCT07775300
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT07775300
- Registry
- ClinicalTrials.gov
- NCT number
- NCT07775300
- CTIS number
- 2025-522310-24-00
- Sponsor, as registered
- Eli Lilly and Company
- Phase
- PHASE3
- Indication
- Depressive Disorder, Major
- Status
- NOT_YET_RECRUITING
- Start date
- 2026-08
- Primary completion
- 2028-12
- Registered countries
- Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, Puerto Rico, South Korea, Spain, Taiwan, United Kingdom, United States
- Sites
- 169
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-08-31
Notes on the record
Fields read from the ClinicalTrials.gov v2 API record. countries is the distinct country list across all registered locations; site_count is the number of location entries, which counts a country once per site, not once per country.
Company
Through brenipatide (LY3537031): Lilly
Cited in
Issues quoting NCT07775300 in their own text.